CDMO Nucleus RadioPharma links up with ARTBIO to help produce prostate cancer candidate for clinical trials News CDMO Nucleus RadioPharma links up with ARTBIO to help produce prostate cancer candidate for clinical trials
ARTBIO and Nucleus RadioPharma Announce Collaboration to Manufacture GMP-Grade Therapeutic Products Containing Radioisotope Pb-212 to Support Emerging Clinical Trials News ARTBIO and Nucleus RadioPharma Announce Collaboration to Manufacture GMP-Grade Therapeutic Products Containing Radioisotope Pb-212 to Support Emerging Clinical Trials
Nucleus RadioPharma Announces Appointment of Chris McDonald from Kite, a Gilead Company, to Board of Directors News Nucleus RadioPharma Announces Appointment of Chris McDonald from Kite, a Gilead Company, to Board of Directors
Eckert & Ziegler to Supply Nucleus RadioPharma with Therapeutic Radioisotopes Ac-225 and Lu-177 News Eckert & Ziegler to Supply Nucleus RadioPharma with Therapeutic Radioisotopes Ac-225 and Lu-177
Nucleus RadioPharma Appoints Former McKesson, Novo Nordisk Executive Kathy Spencer-Pike as Chief Commercial Officer to Drive Business Growth News Nucleus RadioPharma Appoints Former McKesson, Novo Nordisk Executive Kathy Spencer-Pike as Chief Commercial Officer to Drive Business Growth
Nucleus RadioPharma Appoints Industry Veteran Mark Przekop as Chief Operating Officer to Lead Supply Chain Strategy News Nucleus RadioPharma Appoints Industry Veteran Mark Przekop as Chief Operating Officer to Lead Supply Chain Strategy
In the fight against cancer, it’s boom times for radiopharmaceuticals News In the fight against cancer, it’s boom times for radiopharmaceuticals
General Catalyst Combines With European VC La Famiglia News General Catalyst Combines With European VC La Famiglia
With the radiopharma field booming, RLS plans to add CDMO services at 8 US sites News With the radiopharma field booming, RLS plans to add CDMO services at 8 US sites
InnovationRx: Healthtech’s ‘Trough Of Disillusionment’ News InnovationRx: Healthtech’s ‘Trough Of Disillusionment’